Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Karan Chhabra"'
Autor:
MEENU BAJPAI, ASHISH MAHESHWARI, SURESH KUMAR, KARAN CHHABRA, PRATIBHA KALE, ASHAD NARAYANAN, AMITA GUPTA, EKTA GUPTA, NIRUPAMA TREHANPATI, RESHU AGARWAL, KAMINI GUPTA, ANKIT BHARDWAJ, MOJAHIDUL ISLAM, RAVINDER SINGH, PUSHPA YADAV, GURESH KUMAR, SHIV K. SARIN
Publikováno v:
Anais da Academia Brasileira de Ciências, Vol 94, Iss 4 (2022)
Abstract background: Role of Convalescent plasma (COPLA) to treat severe COVID-19 is under investigation. We compared efficacy and safety of COPLA with fresh frozen plasma (FFP) in severe COVID-19 patients. Methods: One group received COPLA with stan
Externí odkaz:
https://doaj.org/article/32d39f9771e94ec18ccce02db649aeef
Autor:
Amita Gupta, Chhagan Bihari, Suresh Kumar, Reshu Agarwal, Guresh Kumar, Ankit Bhardwaj, Shiv Kumar Sarin, Shruti Jain, Ekta Gupta, Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, Pratibha kale, Vandana Saluja, Sherin S Thomas, Nirupama Trehanpati, Praveen Bharti, Prabha Shankar, Javid Hussain, Karan Chhabra, Ashad Narayanan, Sarika Agarwal, Birendra Kumar Yadav
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Importance No proven treatment is available for severely ill COVID-19. Therapeutic use of COVID-19 convalescent plasma (COPLA) is under investigation.Objective To compare the efficacy of COPLA with standard medical therapy (SMT) alone in severe COVID
Externí odkaz:
https://doaj.org/article/9b1efc1c6ad9414ebe93925619045758
Autor:
Punita K Sodhi, Ritu Arora, Suresh Kumar, Kirti Jaisingh, Archana T R., Kavya C Rao, Karan Chhabra, Sonal Saxena, Vikas Manchanda, Shantanu Sharma
Publikováno v:
Cureus.
Autor:
Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, Suresh Kumar, Ekta Gupta, Pratibha kale, Vandana Saluja, Sherin S Thomas, Nirupama Trehanpati, Chhagan Bihari, Reshu Agarwal, Praveen Bharti, Prabha Shankar, Javid Hussain, Karan Chhabra, Amita Gupta, Ashad Narayanan, Sarika Agarwal, Shruti Jain, Ankit Bhardwaj, Guresh Kumar, Birendra Kumar Yadav, Shiv Kumar Sarin
Publikováno v:
BMJ open. 12(4)
ImportanceNo proven treatment is available for severely ill COVID-19. Therapeutic use of COVID-19 convalescent plasma (COPLA) is under investigation.ObjectiveTo compare the efficacy of COPLA with standard medical therapy (SMT) alone in severe COVID-1
Publikováno v:
International Journal of Current Microbiology and Applied Sciences. 8:1497-1505